Skip to content
Menu

Mineralys Therapeutics, Inc. MLYS

Full chart Compare
Set alert

Price alert · MLYS

All alert types
13.66 USD -0.50 (-3.53%)

Regular-session close

13.66 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

13.57 Day range 14.79
13.57 52-week range 44.13
YTD
-62.36%
1 year
-67.38%

Held by funds

111 US ETFs and mutual funds hold MLYS · largest positions

  1. VTI 0.00% of fund $30.20M
  2. FSPHX 0.43% of fund $29.65M
  3. NJM 0.04% of fund $28.10M
  4. ANOIX 0.47% of fund $24.20M
  5. IWM 0.03% of fund $22.51M
  6. ANOGX 0.36% of fund $21.38M
  7. XBI 0.21% of fund $20.86M
  8. FSSNX 0.05% of fund $16.14M
  9. FHCIX 0.45% of fund $15.08M
  10. VXF 0.01% of fund $13.76M
  11. FBTTX 0.45% of fund $10.57M
  12. NLO 0.07% of fund $9.87M
  13. FIDGX 0.11% of fund $9.72M
  14. IWO 0.06% of fund $8.16M
  15. FSMAX 0.02% of fund $7.77M
  16. FBIOX 0.12% of fund $6.91M
  17. VEXRX 0.03% of fund $6.69M
  18. IBB 0.06% of fund $6.69M
  19. VTWO 0.04% of fund $6.56M
  20. FESM 0.08% of fund $5.03M

Ownership

Held by insiders 0.73%
Held by institutions 113.31%
Float held by institutions 114.14%
Institutions 315

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Catalys Pacific, LLC8.81%7,799,518106.54MSep 29, 2026
RA Capital Management, L.P.8.69%7,692,750105.08MSep 29, 2026
Blackrock Inc.6.97%6,172,15384.31MSep 29, 2026
Samsara BioCapital, LLC6.63%5,871,01880.20MSep 29, 2026
FMR, LLC5.32%4,713,19564.38MSep 29, 2026
Deerfield Management Company, L.P4.47%3,958,00054.07MSep 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
SmallCap World Fund Inc2.83%2,502,85434.19MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.22%1,968,12426.88MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.79%1,584,49321.64MSep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.66%1,468,68920.06MSep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio1.33%1,180,00016.12MSep 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund1.09%962,99913.15MSep 29, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs MLYS, and what each was last paid

Jon Congleton, President, Chief Executive Officer & DirectorAverage age 53

MLYS key executives
NameTitlePayAge
Jon CongletonPresident, Chief Executive Officer & Director$1.11M 63
James J. Ferguson FACCChief Medical Officer$882K 72
Adam Scott LevyChief Financial Officer & Secretary$880K 48
Brian Taylor SlingsbyFounder & Executive Director$78.0K 49
Danielle MahoneySenior Vice President of Quality Assurance— —
Eric J. WarrenChief Commercial Officer— 54
Jeffrey A. MunsieChief Legal Officer & Secretary— 49
Jose BretonSenior Vice President of Finance & Controller— 37
Michael TortoriciSenior Vice President of Translational Medicine— —
Robert McKeanSenior Vice President of CMC— —
Jessica IbbitsonExecutive Vice President of Operations— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

MLYS insiders
InsiderRelationLatest transactionDateShares held
AKKARAJU SRINIVASDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Feb 18, 20265,877,220
CONGLETON JONChief Executive OfficerSaleJul 12, 2026603,621
FERGUSON JAMES J. IIIOfficerStock Award(Grant)Aug 9, 2026102,400
KARYDAS DAPHNEDirectorConversion of Exercise of derivative securitySep 14, 20266,200
LEVY ADAM SCOTTChief Financial OfficerStock Award(Grant)Feb 18, 202648,538
RA CAPITAL MANAGEMENT, L.P.Beneficial Owner of more than 10% of a Class of SecurityPurchaseMar 29, 20260